Retraction
Rosiglitazone Suppresses the Growth and Invasiveness of SGC-7901 Gastric Cancer Cells and Angiogenesis In Vitro via PPAR γ Dependent and Independent Mechanisms
Paper Information
Record ID:
24260
Journal:
PPAR Research
(
Hindawi
)
Publication Date:
September 15, 2008
Retraction Date:
September 01, 2020
(5.2 years years ago)
Subjects:
Institutions:
- Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510080, China
- Department of Gastroenterology, Gastroenterology Institute, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510080, China
- Department of Physiology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou 510080, China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Hindawi
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1155/2020/9469261Additional Notes:
See also: https://pubpeer.com/publications/3009BCA859C7F434DD1F7FEC672E0D
Citations (17)
17
Total Citations2
Post-Retraction(11.8%)
13
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
0
Within 30 days
0
Within 1 year
2
After 2+ years
1032
Days since retraction (latest)
Paper citing Rosiglitazone Suppresses the Growth and Invasivene...
Unknown Authors
Unknown Journal
Published: Unknown
ROSIGLITAZONE, A REPURPOSED DRUG AS ANTICANCER AGENT: A REVIEW
Binita Patel, Brijesh Gelat, Kaid Johar
Towards Excellence
Open Access
Published: Jun 2023
1032 days after retraction
Bioinformatics analysis reveals the potential target of rosiglitazone as an antiangiogenic agent for breast cancer therapy
Adam Hermawan, Herwandhani Putri
BMC Genomic Data
Open Access
Published: Sep 2022
7 citations
7 citations
745 days after retraction
Retracted: Rosiglitazone Suppresses the Growth and Invasiveness of SGC-7901 Gastric Cancer Cells and Angiogenesis In Vitro via PPARγ Dependent and Independent Mechanisms
Ppar Research
PPAR Research
Open Access
Published: Sep 2020
Same day as retraction
PPARs and Angiogenesis—Implications in Pathology
Nicole Wagner, Kay‐Dietrich Wagner
International Journal of Molecular Sciences
Open Access
Published: Aug 2020
68 citations
68 citations
22 days before retraction
Pharmacological Strategies for Insulin Sensitivity in Obesity and Cancer: Thiazolidinediones and Metformin
Luana Amorim Biondo, Alexandre Abílio de Souza Teixeira, Karen C. de O. S. Ferreira et al. (4 authors)
Current Pharmaceutical Design
Published: Jan 2020
23 citations
23 citations
222 days before retraction
Receptory aktywowane przez proliferatory peroksysomów w procesie nowotworzenia - fakty i kontrowersje
Anna Szydłowska, Aleksandra Kurzyńska, Zuzanna Kunicka et al. (4 authors)
Kosmos
Open Access
Published: Aug 2018
737 days before retraction
Rosiglitazone diminishes the high-glucose-induced modulation of 5-fluorouracil cytotoxicity in colorectal cancer cells.
Meng Fei Lau, Shalini Vellasamy, Kek Heng Chua et al. (5 authors)
PubMed
Published: Jan 2018
6 citations
6 citations
974 days before retraction
Effects of Thiazolidinediones on metabolism and cancer: Relative influence of PPARγ and IGF-1 signaling
Amreen Mughal, Dinesh Kumar, Ajit Vikram
European Journal of Pharmacology
Published: Nov 2015
28 citations
28 citations
1763 days before retraction
Loss of PTEN Facilitates Rosiglitazone-Mediated Enhancement of Platinum(IV) Complex LA-12-Induced Apoptosis in Colon Cancer Cells
Jarmila Lauková, Alois Kozubı́k, Jiřina Hofmanová et al. (8 authors)
PLoS ONE
Open Access
Published: Oct 2015
6 citations
6 citations
1776 days before retraction
Peroxisome proliferator‐activated receptor γ upregulates galectin‐9 and predicts prognosis in intestinal‐type gastric cancer
Soo‐Jeong Cho, Myeong‐Cherl Kook, Jun Ho Lee et al. (9 authors)
International Journal of Cancer
Published: Jun 2014
31 citations
31 citations
2257 days before retraction
Rosiglitazone Causes Cardiotoxicity via Peroxisome Proliferator-Activated Receptor γ-Independent Mitochondrial Oxidative Stress in Mouse Hearts
Huamei He, Hai Tao, Hui Xiong et al. (7 authors)
Toxicological Sciences
Open Access
Published: Jan 2014
53 citations
53 citations
2415 days before retraction
Effects of rosiglitazone on the growth and lymphangiogenesis of human gastric cancer transplanted in nude mice
Fang-Zhi Chen, Xi-ming Mo, Qingping Wang et al. (5 authors)
Oncology Reports
Open Access
Published: Aug 2013
11 citations
11 citations
2561 days before retraction
Paper citing Rosiglitazone Suppresses the Growth and Invasivene...
Unknown Authors
Unknown Journal
Published: Jun 2013
2649 days before retraction
Rosiglitazone Inhibits Cell Proliferation by Inducing G1 Cell Cycle Arrest and Apoptosis in ADPKD Cyst‐Lining Epithelia Cells
Yawei Liu, Bing Dai, Lili Fu et al. (5 authors)
Basic & Clinical Pharmacology & Toxicology
Open Access
Published: Feb 2010
22 citations
22 citations
3843 days before retraction
Anticancer Role of PPAR<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mi>γ</mml:mi></mml:math>Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes
P. J. Simpson‐Haidaris, Stephen J. Pollock, Sesquile Ramon et al. (7 authors)
PPAR Research
Open Access
Published: Jan 2010
15 citations
15 citations
3896 days before retraction
Induction of Metastatic Gastric Cancer by Peroxisome Proliferator-Activated Receptorδ Activation
Claire B. Pollock, Olga Rodriguez, Philip Martin et al. (7 authors)
PPAR Research
Open Access
Published: Jan 2010
38 citations
38 citations
3896 days before retraction
Quick Stats
Total Citations:
17
Years Since Retraction:
5.2 years
Open Access:
Yes
Last Checked:
Jul 24, 2025